La presentazione è in caricamento. Aspetta per favore

La presentazione è in caricamento. Aspetta per favore

Post-Transplant Cyclophosphamide and Tacrolimus–Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic.

Presentazioni simili


Presentazione sul tema: "Post-Transplant Cyclophosphamide and Tacrolimus–Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic."— Transcript della presentazione:

1 Post-Transplant Cyclophosphamide and Tacrolimus–Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors  Fabrizio Carnevale-Schianca, Daniela Caravelli, Susanna Gallo, Valentina Coha, Lorenzo D'Ambrosio, Elena Vassallo, Marco Fizzotti, Francesca Nesi, Luisa Gioeni, Massimo Berger, Alessandra Polo, Loretta Gammaitoni, Paolo Becco, Lidia Giraudo, Monica Mangioni, Dario Sangiolo, Giovanni Grignani, Delia Rota–Scalabrini, Antonino Sottile, Franca Fagioli, Massimo Aglietta  Biology of Blood and Marrow Transplantation  Volume 23, Issue 3, Pages (March 2017) DOI: /j.bbmt Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

2 Figure 1 Transplant-related complications. (A) Cumulative incidence of aGVHD. (B) Cumulative incidence of cGVHD. (C) Cumulative incidence of NRM. Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

3 Figure 2 Kaplan-Meier survival curves. (A) OS. (B) EFS. (C) Relapse incidence in all patients (solid line) and in patients who underwent BMT with complete remission (CR) of the underlying disease (dashed line). (D) GVHD-EFS. Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions


Scaricare ppt "Post-Transplant Cyclophosphamide and Tacrolimus–Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic."

Presentazioni simili


Annunci Google